One microgram of total RNA was reverse transcribed using Ambion’s RETROscript kit with oligo(dT) primers for the 2-step qRT-PCR assays. Gene specific primers were used to amplify message by qPCR on a Cepheid Smart Cycler (Sunnyvale, CA) using the Qiagen SYBR Green master mix or on an ABI 7500 using the ABI SYBR Green master mix (Foster City, CA). Primer sets were designed against the complete nucleotide sequence, as deposited on GenBank, using Vector NTI 9.0.0 (InforMax, Frederick, MD). The optimum annealing temperature for each primer set was determined prior to the analysis of experimental samples. The specificity of each primer set and molecular weight of the amplicon were monitored by dissociation curve analysis and further verified by analysis using Agilent’s Bioanalyzer 2100. A sample volume of 25 μl was used for all assays, which contained a 1X final concentration of SYBR green PCR master mix, 400 nM gene specific primers, and 1 μl template. All samples and standards were run in triplicate, except for the azaspiracid time course which was run in duplicate. Assays were run using the following protocol: 95°C for 15 min or 10 min (Qiagen or ABI master mix, respectively), 94°for 15 sec, gene specific annealing temperature (55°-64°C) for 40 sec, 72°C for 1 min for 40 cycles, followed by a gradual increase in temperature from 60°C to 95°C during the dissociation stage. Table 3 (in the Supplemental information) details the genes validated by qPCR and assay conditions.
Following amplification, the instrument software was used to set the baseline and threshold for each reaction. A cycle threshold (Ct) was assigned at the beginning of the logarithmic phase of PCR amplification and the difference in the Ct values of the control and experimental samples were used to determine the relative expression of the gene in each sample. Prior to quantitative analysis, a standard curve was constructed using serial dilutions of RT product (species and tissue specific) and the efficiency of each primer set was determined using the equation [(10 (-1/-slope)-1)·100]. Efficiencies of 90-110% were required to include the qPCR assay in array validation. Relative expression levels between samples were then calculated as fold changes, where each PCR cycle represents a two-fold change. Therefore, the assay-specific efficiency was not used in the calculation of relative expression levels. For each experiment, a specific gene was chosen for normalization that did not exhibit any significant change in expression via microarray. All mouse experiments used tubulin, alpha 4 (NM_009447) for normalization while the human AZA study utilized an alpha tubulin-like gene (NM_145042). Statistical analysis was performed using a Wilcoxon/Kruskal-Wallis nonparametric test or a one-way ANOVA in JMP version 5.1.2 (SAS Institute Inc., Cary, NC).
Following amplification, the instrument software was used to set the baseline and threshold for each reaction. A cycle threshold (Ct) was assigned at the beginning of the logarithmic phase of PCR amplification and the difference in the Ct values of the control and experimental samples were used to determine the relative expression of the gene in each sample. Prior to quantitative analysis, a standard curve was constructed using serial dilutions of RT product (species and tissue specific) and the efficiency of each primer set was determined using the equation [(10 (-1/-slope)-1)·100]. Efficiencies of 90-110% were required to include the qPCR assay in array validation. Relative expression levels between samples were then calculated as fold changes, where each PCR cycle represents a two-fold change. Therefore, the assay-specific efficiency was not used in the calculation of relative expression levels. For each experiment, a specific gene was chosen for normalization that did not exhibit any significant change in expression via microarray. All mouse experiments used tubulin, alpha 4 (NM_009447) for normalization while the human AZA study utilized an alpha tubulin-like gene (NM_145042). Statistical analysis was performed using a Wilcoxon/Kruskal-Wallis nonparametric test or a one-way ANOVA in JMP version 5.1.2 (SAS Institute Inc., Cary, NC).